NASDAQ:SCNI

Scinai Immunotherapeutics Ltd.

Company facts

Headquarters
Jerusalem
Most recent report
6-K, filed Oct 16, 2026
Filings on record
493 filings
On EDGAR
CIK 1611747
Fiscal year ends
December
Filer status
Non-accelerated filer

Financials 8 of 292

News 4

Prospectuses and Registrations 8 of 49

Ownership 8 of 56

Other 8 of 92

Everything here comes from Scinai Immunotherapeutics Ltd.'s own filings on SEC EDGAR. The filing list is rechecked every hour.